Take a look at the Recent articles

Evaluation of patients with diffuse pigmented villonodular synovitis of knee with functional scoring systems after surgery and radiosynovectomy

Hasan Ikbal Atilgan

Kahramanmaras Necip Fazil City Hospital, Department of Nuclear Medicine, Kahramanmaras, Turkey

Murat Sadic

Ankara Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey

E-mail : mdmuratsadic@gmail.com

Arzu Ozsoy

3Ankara Numune Hospital, Department of Radiology

Meliha Korkmaz

Ankara Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey

Onur Fakioglu

Hatay Dortyol State Hospital, Department of Orthopedics and Traumatology, Hatay, Turkey

Aylin Baskin-Akbulut

Ankara Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey

Koray Demirel

Ankara Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey

Rahime Orak

Istanbul Haydarpasa Numune Training and Research Hospital, Department of Nuclear Medicine, Istanbul, Turkey

Gokhan Koca

Ankara Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey

DOI: 10.15761/NMBI.1000107

Article
Article Info
Author Info
Figures & Data

Abstract

Aim: To evaluate the symptoms and functional status of patients with pigmented villonodular synovitis (PVNS) of the knee using the modified Marshall scoring system and musculoskeletal tumor society (MSTS) rating scale before therapy and six months after radiosynovectomy (RS).

Materials and methods: Evaluation was made of 29 knee joints of 29 patients with DPVNS. Arthroscopic synovectomy was applied to all patients and additional posterior open synovectomy to five. Yittrium-90 (Y-90) citrate colloid was used in the RS procedure. RS was performed 11.8 ± 13.3 weeks after the operation. In the six months after RS, patients were evaluated with the modified Marshall scoring system and MSTS rating scale.

Results: The patients were 17 females and 12 males with a mean age of 31.8 ± 12.9 years (range: 13-54 years). The preoperative modified Marshall score was poor in 24 patients and fair in five patients. In the follow-up period, the scores were excellent in 17 patients, good in 10 patients and fair in two patients. The mean modified Marshall scores increased after the operation and RS from 12.93 ± 2.93 to 25.52 ± 2.90 (p<0.001).The mean MSTS scores increased from 17.52 ± 4.82 to 26.86 ± 2.46 (p<0.001). In one of four patients with a score of 22 and three patients with a score of 24, maximum scores were obtained in the follow-up period with the effect of surgery and RS.

Conclusion: RS with Y-90 citrate colloid after surgical excision in the treatment of PVNS is a reliable and efficient treatment method for the increase of functional capacity and decrease of symptoms.

Key words

pigmented villonodular synovitis (PVNS), radiosynovectomy, arthroscopic synovectomy

Introduction

Pigmented villonodular synovitis (PVNS) is a rare proliferative disease of the synovium with locally aggressive behaviour and high relapse rates after surgical removal [1]. The etiology of PVNS is unknown but the possible mechanism is thought to be associated with reactive process, repetitive microtraumatic or inflammatory events with synovial hemosiderin deposition [2]. Histology reveals hypertrophic synovium with villous, nodular and villonodular proliferation and pigmentation from hemosiderin [3]. PVNS is a benign and destructive disease which results in major symptoms and loss of function leading to amputation [4]. The clinical symptoms are mostly chronic, and years may pass from the first symptoms to medical presentation. In the advanced stages, a synovial mass may invade the chondro-osseous junction with joint destruction [5]. PVNS of the knee has been reported to have a higher recurrence rate when compared with PVNS of other joints [6]. Surgical excision is the treatment of choice with wide excision in localised disease and total synovectomy in the diffuse form [7].

Radiotherapy or intra-articular isotope injection, known as radiosynovectomy may be necessary after tumor resection. Radionuclide emits β-particles which are injected into the articular cavity. Synovial lining cells phagocytise the colloidal particles. Active irradiation with β-particles of the surrounding synovial tissues causes fibrosis and sclerosis of the synovial membrane [8]. Radionuclide choice depends on the synovial thickness in the treated joint and the penetration rate of the β-particles. Y-90 is used in the knee joint due to the high mean tissue penetration of 3.6 mm [9]. Yittrium-90 emits β-particles of 2.27 MeV with a physical half life of 64 hours [10].

In this study, the symptoms and functional status were evaluated of patients with PVNS of the knee using the modified Marshall scoring system and musculoskeletal tumor society (MSTS) rating scale before therapy and six months after RS.

Materials and methods

Evaluaton was made of 29 knee joints of 29 patients with a diagnosis of histopathological diffuse PVNS. The patients were 17 females and 12 males with a mean age of 31.8 ± 12.9 years (range 13-54 years). All patients underwent arthroscopic surgery and posterior open synovectomy for posterior extra-articular masses was also applied to five patients. RS was performed at 11.8 ± 13.3 weeks postoperatively. Written informed consent was obtained from all patients or the parents of those aged under 18 years.

Procedure of arthroscopic synovectomy

Pneumatic tourniquet with 300 mm Hg was used to achieve bloodless field for arthroscopic synovectomy. Anteromedial, anterolateral, suprapatellar medial and lateral portals, posteromedial, posterolateral and transpatellar tendon portal were used for near-complete arthroscopic synovectomy. Cryo-cuff was used to decrease pain and inflammation and suction drain was kept in the joint for 48 hours. Home exercises were advised for strengthening quadricaps and range of motion.

Procedure of radiosynovectomy

RS was performed with 185 mBq (5 mCi) Y-90 citrate colloid (CIS Bio International, France) under aseptic conditions. In cases of excess effusion in the joint, fluid was drained before the Y-90 citrate colloid injection. After injection of Y-90 citrate colloid, another syringe with prilocaine (Citanest, AstraZeneca, London, UK) was injected into the knee joint to provide analgesia and to prevent extra-articular leakage of radionuclide. After two minutes of manual pressure to the puncture site, passive flexion-extension of the knee was applied to achieve homogenous distribution of the radionuclide in the joint space. At four and 48-72 hours after RS, whole body and static imaging using Bremsstrahlung settings with General Electric (GE) Millennium MG (Germany) was taken to assess the distribution and leakage of radionuclide in the knee joint. The joint was immobilized for 48-72 hours with a splint to minimize extra-articular leakage. Patients were warned to avoid excessive physical activity for two weeks.

Preoperative and follow-up evaluation

Preoperatively and at six months after RS, the functional results were assessed with the modified Marshall scoring system with a maximum score of 30 points. Below 16 points was evaluated as a poor functional result, 16-20 points as fair, 21-25 points as good and 26-30 points as excellent [11,12] (Table 1). The MSTS rating scale was also applied. This scale has six categories of pain, function, emotional acceptance, support, walking ability and gait with each category rated on a scale of 0-5, where 0 represents poor function and 5 normal functions. The maximum possible score is 30 points [13].

Table 1. Modified Marshall knee scoring scale

Criteria Points
Subjective  
Pain 0=yes, 1=no
Swelling 0, 1
stair difficulty 0, 1
Clicking, numbness 0, 1
Giving way 0-4
Normal
With Athletic Activity Only
With Stress Upon ADL
Regularly Upon ADL
4
2
1
0
Return to sports or work 0-3
Return, no limitations
Return, some limitations
Change in occupation
Cannot work
3
2
1
0
Objective  
Functional tests  
Duck Walk
Run in place
Jump one leg
Half squat
Full squat
0, 1, 2
0, 1
0, 1,, 2
0, 1,
0, 1,
Specific knee examination  
Tenderness
Joint effusion
Swelling (soft tissue)
Crepitation
Muscle power
Normal (5)
Mild weakness (4+, 4)
Moderate weakness (4-, 3+)
Severe weakness (3 or less)
0, 1
0, 1
0, 1
0, 1
0-3
3
2
1
0
Thigh sizes 0-2
Equal
1-2 cm difference
>2 cm difference
2
1
0
Range of motion 0-3
Normal
5 degree extension lossand/or 10 degree flexion loss
10 degree extension loss and/or 20 degree flexion loss
>10 degree extension loss and/or >20 degree flexion loss
3
2
1
0
Total points 30

ADL: Activities of daily living, 2 = performance without discomfort, 1= performance with discomfort, 0 = cannot perform

Statistical analysis

Data obtained from the application of the modified Marshall scoring system and MSTS rating scale were analysed using Statistical Package for Social Sciences (SPSS for Windows 16.0). The scores obtained preoperatively and at six months after RS in the Modified Marshall and MSTS scales were compared with the paired sample t test.

Results

Bremsstrahlung imaging revealed an even distribution of radionuclide in all the knee joints and no evidence of extra-articular leakage of radioactivity (Figure 1).

Figure 1. Distribution of radionuclide in all the knee joints.

The patients were 17 females and 12 males with a mean age of 31.8 ± 12.9 years (range: 13-54 years). The preoperative modified Marshall score was determined as poor in 24 patients and fair in five patients. No patient had a preoperative score greater than 19. In the follow-up period, the modified Marshall score was evaluated as excellent in 17 patients, good in 10 patients and fair in two patients. No patient had a functional score of less than 16 at six months after RS. Of the 24 patients with a poor preoperative functional score, two were evaluated as fair, nine as good and 13 as excellent in the follow-up period. The modified Marshall scores were 12.93 ± 2.93 (range: 6-19) preoperatively and 25.52 ± 2.90 (range: 16-29) at six months after RS. The increase in the modified Marshall scores were statistically significant (p<0.001) (Table 2).

Table 2. Distribution of preoperative and follow-up functional scores (p<0.001).

Preoperative Follow-up
Poor score 24 0
Fair score 5 2
Good score 0 10
Excellent score 0 17

MSTS scores were 17.52 ± 4.82 (range: 8-24) preoperatively and 26.86 ± 2.46 (range: 20-30) at six months after RS The increase in the MSTS scores were statistically significant (p<0.001). In one of four patients with a preoperative score of 22 and three patients with a score of 24, maximum scores were obtained in the follow-up period with the effect of surgery and RS.

Discussion

PVNS typically occurs before the age of 40 years, presents with pain, swelling and dysfunction in the joints and the knee is the most involved joint [14]. Recurrence rates of PVNS increase with time and as time passes, it becomes increasingly difficult to cure. The quality of life decreases for PVNS patients when compared with the general population [15]. Surgery may not remove all the tissue and RS should be discussed to remove the residue of the synovial membrane in 6-8 weeks after the operation [16]. The use of RS has been shown to be effective in some diseases that involve joints. Improvement rates after RS have been reported as 66.7% in rheumatoid arthritis, 56% in osteoarthritis, and 77.3% in PVNS. Reduction in joint bleeding and factor usage has been shown to be evident in 91% of cases of haemophilia and Willebrand’s disease. Treatment failure is especially seen in deformed and unstable joints [17].

Wu et al. applied anterior and posterior open synovectomies with external radiation therapy. The mean knee rating and functional rating improved from 65.2 and 70 preoperatively to 93.7 and 96.6 postoperatively. Of nine patients in the series, eight were disease free and one had local recurrence [18]. Nassar et al. used external beam radiotherapy after debulking surgery and reported no disease recurrence or progression of bone or articular destruction in any patient, nor any complication related to the surgical procedure or radiotherapy [19].

Oztemur et al. applied Y-90 RSV to 17 knees of 17 patients for the treatment of resistant chronic non-specific synovitis and evaluated the efficacy of RSV with the Lysholm score. The combination of RSV with surgical synovectomy was reported to be an effective and reliable treatment method in repetitive, chronic, non-specific synovitis [20]. De Carvalho Jr et al. applied external beam radiotherapy after subtotal arthroscopic and open synovectomy and had a recurrence rate of 12.5% at 8.6 years of follow-up for the treatment of diffuse PVNS of the knee joint [21]. Heyd et al. suggested the use of radiation therapy in the postoperative setting after incomplete resection and for the treatment of recurrences [5].

Ozturk et al. applied the combination of debulking surgery with Y-90 RSV to a small group of seven patients. Synovial thickness disappeared and joint effusion decreased [22]. Zook et al. administered 11 injections of P-32 to nine patients, eight of whom had PVNS in the knee and one with involvement of the hip with an overall control rate of 70% [14]. Franssen et al. performed Y-90 RSV to diffuse PVNS and recommended Y-90 as an alternative treatment without previous surgical synovectomy or for cases with failure of previous surgical synovectomy [23]. Koca et al. applied Y-90 citrate to 15 knee joints and the MRI examination showed no progression, as two cases were seen to be stable, regression was seen in nine and total cure in four cases. The Lysholm score increased from 39 before surgical excision to 83 at the final follow-up examination (24). Shabat et al. combined Y-90 RSV and traditional open synovectomy in 10 patients with six knees, three ankles and one hip joint. In one patient, disease was stable with no further joint damage and nine patients had no local recurrence and no progressive bone or joint destruction [25].

Jahangier et al. applied second RSV at a double dose when the initial response was inadequate, but the second application with double dose did not contribute to a better result. It was reported that persistent synovitis can be treated with a success rate of 75% in the first month, but prolonged remission was only achieved in 29% of joints [26]. Kamaleshwaran et al. used 370 mBq (10 mCi) Y-90 as a primary treatment in the knee joint with diffuse PVNS and obtained pain relief, a decrease in joint swelling and an increase in joint mobility [27].

In the current study, the modified Marshall and MSTS scores increased with the therapeutic effect of the surgery and RS in patients with diffuse PVNS. RS should be applied for an increase in functional capacity and a decrease in symptoms.

Conflict of interest

The authors state that there is no conflict of interest in this paper.

Acknowledgement

None

References

  1. Horoschak M,  Tran PT, Bachireddy P, West RB, Mohler D, et al. (2009) External beam radiation therapy enhances local control in pigmented villonodular synovitis.  Int J Radiat Oncol Biol Phys 75: 183-187. [Crossref]
  2. Berger B, Ganswindt U, Bamberg M, Hehr T (2007) External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 67: 1130-4.
  3. Ottaviani S,  Ayral X, Dougados M, Gossec L (2011) Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature.  Semin Arthritis Rheum 40: 539-546. [Crossref]
  4. O'Sullivan B,  Cummings B, Catton C, Bell R, Davis A, et al. (1995) Outcome following radiation treatment for high-risk pigmented villonodular synovitis.  Int J Radiat Oncol Biol Phys 32: 777-786. [Crossref]
  5. Heyd R, Micke O, Berger B, Eich HT, Ackermann H, Seegenschmiedt MH, et al. (2010) Radiation therapy for treatment of pigmented villonodular synovitis: results of national patterns of care study. Int J Radiat Oncol Biol Phys 78: 199-204.
  6. Park G,  Kim YS, Kim JH, Lee SW, Song SY, et al. (2012) Low-dose external beam radiotherapy as a postoperative treatment for patients with diffuse pigmented villonodular synovitis of the knee: 4 recurrences in 23 patients followed for mean 9 years.  Acta Orthop 83: 256-260. [Crossref]
  7. Sharma H, Jane MJ, Reid R (2008) Pigmented villonodular synovitis: Diagnostic pitfalls and management strategy. Current Orthopaedics 19: 215-222.
  8. Kisielinski K, Bremer D, Knutsen A, Röttger P, Fitzek JG (2010) Complications following radiosynoviorthesis in osteoarthritis and arthroplasty: osteonecrosis and intra-articular infection. Joint Bone Spine 77: 252-257.
  9. Oztemür Z,  Bulut O, Korkmaz M, Gölge UH, Oztürk H, et al. (2013) Surgical synovectomy combined with yttrium 90 in patients with recurrent joint synovitis.  Rheumatol Int 33: 1321-1326. [Crossref]
  10. Bickels J, Isaakov J, Kollender Y, Meller I (2008) Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis. J Bone Joint Surg Am 90: 326-328.
  11. Asik M,  Sen C, Erginsu M (2002) Arthroscopic meniscal repair using T-fix.  Knee Surg Sports Traumatol Arthrosc 10: 284-288. [Crossref]
  12. Stone RG,  Frewin PR, Gonzales S (1990) Long-term assessment of arthroscopic meniscus repair: a two- to six-year follow-up study.  Arthroscopy 6: 73-78. [Crossref]
  13. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. (1993) A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 286: 241-246.
  14. Zook JE,  Wurtz DL, Cummings JE, Cárdenes HR (2011) Intra-articular chromic phosphate (³²P) in the treatment of diffuse pigmented villonodular synovitis.  Brachytherapy 10: 190-194. [Crossref]
  15. Verspoor FG,  Zee AA, Hannink G, van der Geest IC, Veth RP, et al. (2014) Long-term follow-up results of primary and recurrent pigmented villonodular synovitis.  Rheumatology (Oxford) 53: 2063-2070. [Crossref]
  16. Ganse B,  Behrens P, Gellissen J, Krüger S, Benthien JP (2006) Localized nodular pigmented villonodular synovitis of the upper ankle joint--diagnosis and treatment.  Z Rheumatol 65: 231-234. [Crossref]
  17. Kresnik E,  Mikosch P, Gallowitsch HJ, Jesenko R, Just H, et al. (2002) Clinical outcome of radiosynoviorthesis: a meta-analysis including 2190 treated joints.  Nucl Med Commun 23: 683-688. [Crossref]
  18. Wu CC, Pritsch T, Bickels J, Wienberg T, Malawer MM (2007) Two incision synovectomy and radiation treatment for diffuse pigmented villonodular synovitis of the knee with extra-articular component. Knee 14: 99-106.
  19. Nassar WA,  Bassiony AA, Elghazaly HA (2009) Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy.  HSS J 5: 19-23. [Crossref]
  20. Oztemür Z, Bulut O, Korkmaz M, Oztürk H, Tezeren G (2013) [Radiation synovectomy therapy combined with surgical synovectomy in chronic nonspecific synovitis of the knee joint]. Eklem Hastalik Cerrahisi 24: 18-22.
  21. de Carvalho LH Jr, Soares LF, Gonçalves MB, Temponi EF, de Melo Silva O Jr (2012) Long-term success in the treatment of diffuse pigmented villonodular synovitis of the knee with subtotal synovectomy and radiotherapy. Arthroscopy 28: 1271-1274.
  22. Ozturk H,  Bulut O, Oztemur Z, Bulut S (2008) Pigmented villonodular synovitis managed by Yttrium 90 after debulking surgery.  Saudi Med J 29: 1197-1200. [Crossref]
  23. Franssen MJ, Boerbooms AM, Karthaus RP, Buijs WC, van de Putte LB (1989) Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements. Ann Rheum Dis 48: 1007-1013.
  24. Koca G,  Ozsoy H, Atilgan HI, Ozyurt S, Demirel K, et al. (2013) A low recurrence rate is possible with a combination of surgery and radiosynovectomy for diffuse pigmented villonodular synovitis of the knee.  Clin Nucl Med 38: 608-615. [Crossref]
  25. Shabat S, Kollender Y, Merimsky O, Isakov J, Flusser G, Nyska M, et al. (2002) The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford). 41: 1113-1118.
  26. Jahangier ZN, Jacobs JW, van Isselt JW, Bijlsma JW (1997) Persistent synovitis treated with radiation synovectomy using yttrium-90: a retrospective evaluation of 83 procedures for 45 patients. Br J Rheumatol 36: 861-869.
  27. Kamaleshwaran KK, Rajan D, Krishnan B, Gounder TS, Chakraborty S, Kalarickal R, et al. (2015)  Use of yttrium-90 hydroxyapatite radiosynovectomy as a primary modality of treatment in diffuse pigmented villonodular synovitis of the knee joint: A first case report. Indian J Nucl Med 30: 47-50.

Article Type

Research Article

Publication history

Received: May 21, 2016
Accepted: June 16, 2016
Published:June 20, 2016

Copyright

©2016 Sadic M, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation

Atilgan HI, Sadic M, Ozsoy A, Korkmaz M, Fakioglu O, et al. (2016) Evaluation of patients with diffuse pigmented villonodular synovitis of knee with functional scoring systems after surgery and radiosynovectomy. Nucl Med Biomed Imaging 1: DOI: 10.15761/NMBI.1000107

Corresponding author

Murat Sadic

Department of Nuclear Medicine, University of Health Science, Ankara Training and Research Hospital, Ankara/Turkey.

E-mail : mdmuratsadic@gmail.com

Figure 1. Distribution of radionuclide in all the knee joints.

Table 1. Modified Marshall knee scoring scale

Criteria Points
Subjective  
Pain 0=yes, 1=no
Swelling 0, 1
stair difficulty 0, 1
Clicking, numbness 0, 1
Giving way 0-4
Normal
With Athletic Activity Only
With Stress Upon ADL
Regularly Upon ADL
4
2
1
0
Return to sports or work 0-3
Return, no limitations
Return, some limitations
Change in occupation
Cannot work
3
2
1
0
Objective  
Functional tests  
Duck Walk
Run in place
Jump one leg
Half squat
Full squat
0, 1, 2
0, 1
0, 1,, 2
0, 1,
0, 1,
Specific knee examination  
Tenderness
Joint effusion
Swelling (soft tissue)
Crepitation
Muscle power
Normal (5)
Mild weakness (4+, 4)
Moderate weakness (4-, 3+)
Severe weakness (3 or less)
0, 1
0, 1
0, 1
0, 1
0-3
3
2
1
0
Thigh sizes 0-2
Equal
1-2 cm difference
>2 cm difference
2
1
0
Range of motion 0-3
Normal
5 degree extension lossand/or 10 degree flexion loss
10 degree extension loss and/or 20 degree flexion loss
>10 degree extension loss and/or >20 degree flexion loss
3
2
1
0
Total points 30

ADL: Activities of daily living, 2 = performance without discomfort, 1= performance with discomfort, 0 = cannot perform

Table 2. Distribution of preoperative and follow-up functional scores (p<0.001).

Preoperative Follow-up
Poor score 24 0
Fair score 5 2
Good score 0 10
Excellent score 0 17